Resverlogix (TSE:RVX) Hits New 12-Month Low – Should You Sell?

by · The Markets Daily

Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price reached a new 52-week low on Thursday. The stock traded as low as C$0.09 and last traded at C$0.09, with a volume of 23,300 shares changing hands. The stock had previously closed at C$0.08.

Resverlogix Stock Performance

The company has a current ratio of 0.04, a quick ratio of 0.04 and a debt-to-equity ratio of -82.47. The stock’s 50 day moving average is C$0.09 and its 200 day moving average is C$0.10. The stock has a market capitalization of C$29.26 million, a price-to-earnings ratio of -2.12 and a beta of -0.11.

About Resverlogix

(Get Free Report)

Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease. Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients’ lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.

Further Reading